直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Hatch-Waxman and Follow-On Biologics: Strategies for Protecting Your Innovative Products

October 6, 2011

Cambridge, MA

Effective and cost-efficient legal guidance now, more than ever, is essential for the protection of innovator small molecule and biologic pharmaceutical products. During this program our panelists will discuss:

• An Overview of the Follow-On Biologics Framework 

• Strategies for Successfully Litigating Hatch-Waxman and Biosimilar Cases 

• Strategies for Maximizing Small Molecule and Biosimilar Patent Protection

Where:

Finnegan

55 Cambridge Parkway

Cambridge, MA 02142

Related Practices

Global IP Enforcement, Litigation, and Trials

Branded Hatch-Waxman (ANDA) Litigation and Trials

Related Industries

Life Sciences

Biotechnology

Biologics

Related Offices

Boston, MA

Related Insights

Conference

13th Annual Summit for Women Leaders in Life Sciences Law

July 29-30, 2026

Boston

Webinar

Successful Strategies to Win Alice Motions and Fee Awards in Patent Cases Against Non-Practicing Entities

July 22, 2026

Webinar

Federal Circuit IP Blog

Federal Circuit Affirms Noninfringement Ruling in Hatch-Waxman Litigation Based on Claim Construction, Prosecution History Estoppel, and the Disclosure-Dedication Rule

June 26, 2026

Federal Circuit IP Blog

Redesigns Done Right at the ITC: Federal Circuit Affirms ITC Determination of Noninfringement of Redesigned Products

June 26, 2026

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Lecture

Latest Developments in U.S. Section 337 Investigations and Response Strategies

June 12, 2026

Dongguan

European IP Blog

UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir

8 June 2026

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Conference

BIA Start-up Festival

May 21, 2026

London

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP